PLSE
Pulse Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website ulsebiosciences.com
- Employees(FY) 61
- ISIN US74587B1017
Performance
-20.16%
1W
-16.1%
1M
-4.96%
3M
+34.65%
6M
+36.19%
YTD
+81.59%
1Y
Profile
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.
Technical Analysis of PLSE 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-26 14:47
- 2024-11-15 06:14
- 2024-10-31 15:24
- 2024-10-31 14:25
- 2024-10-31 13:58
Q3 2024 Pulse Biosciences Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-10-31 05:01
- 2024-10-31 02:25
- 2024-10-30 16:05
- 2024-10-30 16:02
- 2024-10-30 04:05
- 2024-10-30 04:02
- 2024-10-21 08:00
- 2024-10-20 20:00
- 2024-08-21 07:55
- 2024-08-13 12:38
Q2 2024 Pulse Biosciences Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-08-12 16:05
- 2024-08-12 16:01
- 2024-08-12 04:05
- 2024-08-12 04:01
- 2024-08-09 06:32
Pulse Biosciences launches first-in-human pulsed field ablation trial(Medical Device Network)
- 2024-08-08 08:00
- 2024-08-07 20:00
- 2024-08-01 16:05
- 2024-08-01 04:05
- 2024-07-29 16:05
- 2024-07-29 04:05
- 2024-07-15 15:39
- 2024-07-09 07:27
- 2024-07-09 06:53
Pulse Biosciences receives breakthrough device status for CellFX system(Medical Device Network)
- 2024-07-08 13:24
Top Midday Gainers(MT Newswires)
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.